Market Place
Sourcing Support
Cohance Lifesciences Names Yann D`Herve as CDMO Business CEO
30 Jul 2025 //
PRESS RELEASE
Cohance Appoints Yann D`Herve as CEO of CDMO Business
28 Jul 2025 //
PRESS RELEASE
Cohance Lifesciences to sell CR Bio assets to Chromo Laboratories
23 Jun 2025 //
INDPHARMAPOST
Suven Pharmaceuticals is now Cohance Lifesciences
08 May 2025 //
PRESS RELEASE
Effective date for Scheme of Amalgamation
25 Apr 2025 //
PRESS RELEASE
Suven to Acquire Controlling stake in NJ Bio
07 Dec 2024 //
PRESS RELEASE
Suven Pharmaceuticals names Mr. Vivek as Executive Chairman
19 Sep 2024 //
PRESS RELEASE
Suven Pharma reports FY24 2Q & Half yearly FY Results
09 Aug 2024 //
PRESS RELEASE
Suven Pharmaceuticals announces Q1 FY25 Financial Results
08 Aug 2024 //
PRESS RELEASE
Suven to Acquire a Majority Stake In an Oligonucleotide Focused
13 Jun 2024 //
PRESS RELEASE
Suven, with Cohance and more, wants to become a CDMO powerhouse
02 Mar 2024 //
ECONOMIC TIMES
Suven-Cohance Lifesciences merger announced
29 Feb 2024 //
PRESS RELEASE
Advent Launches New Brand For Its API Platform
04 Jan 2023 //
PRESS RELEASE
Advent launches Cohance Lifesciences, a new brand identity for its API platform
01 Nov 2022 //
PRESS RELEASE
PE fund Advent International buys controlling stake in API manufacturer RA Chem
29 Jul 2020 //
ECONOMICTIMES
Avra Laboratories gets CDSCO nod to make Favipiravir API
27 Jul 2020 //
MONEYCONTROL
Avra Labs to manufacture favipiravir for Cipla’s Ciplenza launch
26 Jul 2020 //
PHARMABIZ
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.